Preoperative Outcome Predictors in Aortic Valve Replacement: A Single-Center Retrospective Study
- PMID: 40806817
- PMCID: PMC12346984
- DOI: 10.3390/jcm14155196
Preoperative Outcome Predictors in Aortic Valve Replacement: A Single-Center Retrospective Study
Abstract
Background: Several blood biomarkers have shown a major role in predicting major adverse complications (MACs) in patients who have undergone cardiac surgery. Here, we aimed to investigate the possible role of the blood urea nitrogen (BUN) to serum albumin ratio (BAR) and the inflammatory prognostic index (IPI) in predicting major adverse complication after surgical aorta valve replacement (SAVR). Methods: The clinical, echocardiographic, and clinical-chemistry laboratory data of 195 patients who underwent SAVR were evaluated. The post-surgical MACs (death, surgical re-exploration, myocardial infarction and cerebral ischemia) during the hospitalization were recorded. Univariate and multivariate logistic regression analyses were studied by comparing the basic clinical features, echocardiographic parameters, and patients' hematological indices between patients with or without MACs. Results: The mean age was 66.1 years, and 62.5% were males. Logistic regression analysis showed that the left atrium volume (LAV), BAR, and IPI as either continuous or categorical variables were independently associated with MACs. Moreover, we found a combined effect of higher LAV with a higher value of BAR or IPI. Combined higher levels of LAV and BAR increased the risk of developing MACs by 9.8 (CI 95% = 2.8-34.3, p = 0.0003), while higher values of LAV and IPI increased the risk of developing MACs by 4.5. Conclusions: Higher levels of BAR and IPI, alone or in combination with higher LAVs, showed an independent predictive value of MACs after SAVR. These findings strongly support the importance of evaluating easily available biomarkers of the pre-operative status of patients in order to predict adverse outcomes.
Keywords: aortic valve replacement; inflammatory prognostic index (IPI); outcome predictors; serum albumin ratio (BAR).
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2. Cochrane Database Syst Rev. 2021. PMID: 34931303 Free PMC article.
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Association Between Blood Urea Nitrogen to Serum Albumin Ratio and Mortality in Critically Ill Patients With Chronic Obstructive Pulmonary Disease: A Retrospective Study.Int J Chron Obstruct Pulmon Dis. 2025 Feb 17;20:349-360. doi: 10.2147/COPD.S503228. eCollection 2025. Int J Chron Obstruct Pulmon Dis. 2025. PMID: 39991072 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Limited versus full sternotomy for aortic valve replacement.Cochrane Database Syst Rev. 2017 Apr 10;4(4):CD011793. doi: 10.1002/14651858.CD011793.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2023 Dec 6;12:CD011793. doi: 10.1002/14651858.CD011793.pub3. PMID: 28394022 Free PMC article. Updated.
References
-
- Vahanian A., Beyersdorf F., Praz F., Milojevic M., Baldus S., Bauersachs J., Capodanno D., Conradi L., De Bonis M., De Paulis R., et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease: Developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur. Heart J. 2022;43:561–632. doi: 10.1093/eurheartj/ehab395. - DOI - PubMed
-
- Otto C.M., Nishimura R.A., Bonow R.O., Carabello B.A., Erwin J.P., 3rd, Gentile F., Jneid H., Krieger E.V., Mack M., McLeod C., et al. 2020 ACC/AHA guideline for the Management of Patients with Valvular Heart Disease: A report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2021;143:e35–e71. doi: 10.1161/CIR.0000000000000932. - DOI - PubMed
-
- Crawford T.C., Magruder J.T., Grimm J.C., Suarez-Pierre A., Sciortino C.M., Mandal K., Zehr K.J., Conte J.V., Higgins R.S., Cameron D.E., et al. Complications after cardiac operations: All are not created equal. Ann. Thorac. Surg. 2017;103:32–40. doi: 10.1016/j.athoracsur.2016.10.022. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous